BioSpace News Archive

Inteleos, a global non-profit healthcare certification organization, announced that its Point-of-Care Ultrasound Certification Academy launched its comprehensive Maternal Fetal Health Certification, with its new Obstetrics 2nd/3rd Trimester Clinical Certificate.

TransMedics Group, Inc. announced that on June 18, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 1,002 shares of its common stock and an aggregate of 657 restricted stock units to 1 employee, each as a material inducement for the employee’s entry into employment with TransMedics.

AriBio Co., Ltd. announces the expansion of testing for Alzheimer’s disease by entering into a strategic collaboration with Kentucky Clinical Trial Laboratory for the testing of cerebral spinal fluid to accurately and efficiently aid in the diagnosis of Alzheimer’s disease using the Lumipulse® system from FujireBio.

Ocugen, Inc. today announced that the Data and Safety Monitoring Board (DSMB) for the OCU410ST GARDian clinical trial recently convened and approved to proceed with dosing the high dose of OCU410ST in the dose-escalation phase of the study.

Mind Medicine announced today that members of the Company’s management team will present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference being held on June 27, 2024.

Clene Inc. today announced it presented new, preliminary data demonstrating the potential of CNM-Au8 as a treatment for Rett Syndrome.

Pierre Fabre Laboratories has been awarded the “Prix Galien International” Prize in the “Best Product for a Rare/Orphan Disease” category for EBVALLO®.

Avantor, Inc. announced that Corey Walker has rejoined the company as President of Avantor’s Laboratory Solutions business, reporting to CEO Michael Stubblefield.

Acasti Pharma Inc. today announced financial results and business highlights for the year ended March 31, 2024.

Genetic Technologies Limited is pleased to invite investors to a webinar on June 27, 2024, at 4:15 p.m. ET.